vTv Therapeutics Inc. Cl A | Mutual Funds
Mutual Funds that own vTv Therapeutics Inc. Cl A
Franklin Biotechnology Discovery Fund
317,100
2.77%
0
0.02%
03/31/2018
APO Medical Opportunities Institutionell
99,000
0.87%
0
0.05%
06/29/2018
Vanguard Extended Market Index Fund
94,591
0.83%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
60,000
0.52%
0
0.02%
12/31/2017
Tredje AP Fonden
32,934
0.28%
0
0%
06/30/2017
JPMorgan Insurance Trust - Small Cap Core Portfolio
31,900
0.28%
11,300
0.02%
03/31/2018
Fidelity Nasdaq Composite Index
25,511
0.22%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
25,196
0.22%
0
0%
07/31/2018
iShares Micro Cap ETF
16,236
0.14%
0
0%
09/06/2018
CREF Stock Account
15,064
0.13%
0
0%
03/31/2018
| Address |
4170 Mendenhall Oaks Parkway
High Point North Carolina 27265
United States
|
|
Employees
|
- |
| Website |
http://www.vtvtherapeutics.com |
| Updated |
07/08/2019 |
| vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical holding company. The firm engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. |
